Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
752
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Autolus Therapeutics plc - ADR market cap is $241.65M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Autolus Therapeutics plc - ADR 52 week high is $2.58 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Autolus Therapeutics plc - ADR 52 week low is $0.8963 as of November 21, 2026.
Autolus Therapeutics plc - ADR stock price today is $0.9073.
Autolus Therapeutics plc - ADR stock price yesterday was $0.9796.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Autolus Therapeutics plc - ADR's P/E ratio is -0.94.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Autolus Therapeutics plc - ADR P/B ratio is 11.7663.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Autolus Therapeutics plc - ADR 50-day moving average is $1.60.